Acknowledgement
Supported by : National Cancer Center
References
- Beck, A., Etienne, M.C., Cheradame, S., Fischel, J.L., Formento, P., Renee, N., and Milano, G. (1994). A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil. Eur. J. Cancer 30A, 1517-1522
- Brenner, S. (1974). The genetics of caenorthabditis elegans. Genetics 77, 71-94
- Habara, K., Ajiki, T., Kamigaki, T., Nakamura, T., and Kuroda, Y. (2001). High expression of thymidylate synthase leads to resistance to 5-fluorouracil in biliary tract carcinoma in vitro. Jpn. J. Cancer Res. 92, 1127-1132
- Hooiveld, E.A., van Kuilenburg, A.B., Haanen, J.B., and Westermann, A.M. (2004). Severe toxicity after treatment with capecitabine and fluorouracil due to partial dihydropyrimidine dehydrogenase deficiency. Nederlands tijdschrift voor geneeskunde 148, 626-628
- Ishikawa, Y., Kubota, T., Otani, Y., Watanabe, M., Teramoto, T., Kumai, K., Kitajima, M., Takechi, T., Okabe, H., and Fukushima, M. (1999). Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the antitumor effect of 5- fluorouracil on human tumor xenografts in nude mice. Clin. Cancer Res. 5, 883-889
- Kamath, R.S., Fraser, A.G., Dong, Y., Poulin, G., Durbin, R., Gotta, M., Kanapin, A., Le Bot, N., Moreno, S., Sohrmann, M., et al. (2003). Systematic functional analysis of the caenorthabditis elegans genome using RNAi. Nature 421, 231-237 https://doi.org/10.1038/nature01278
- Katona, C., Kralovanszky, J., Rosta, A., Pandi, E., Fonyad, G., Toth, K., and Jeney, A. (1998). Putative role of dihydropyrimidine dehydrogenase in the toxic side effect of 5-fluorouracil in colorectal cancer patients. Oncology 55, 468-474 https://doi.org/10.1159/000011897
- Kim, S., and Shim, J. (2008). A forward genetic approach for analyzing the mechanism of resistance to the anti-cancer drug, 5- fluorouracil, using Caenorhabditis elegans. Mol. Cells 25, 119- 123
- Lackner, M.R., Kindt, R.M., Carroll, P.M., Brown, K., Cancilla, M.R., Chen, C., de Silva, H., Franke, Y., Guan, B., Heuer, T., et al. (2005). Chemical genetics identifies Rab geranylgeranyl transferase as an apoptotic target of farnesyl transferase inhibitors. Cancer Cell 7, 325-336 https://doi.org/10.1016/j.ccr.2005.03.024
- Liu, J., Schmitz, J.C., Lin, X., Tai, N., Yan, W., Farrell, M., Bailly, M., Chen, T., and Chu, E. (2002). Thymidylate synthase as a translational regulator of cellular gene expression. Biochim. Biophys. Acta 1587, 174-182 https://doi.org/10.1016/S0925-4439(02)00080-7
- Maring, J.G., Groen, H.J., Wachters, F.M., Uges, D.R., and de Vries, E.G. (2005). Genetic factors influencing pyrimidine-antagonist chemotherapy. The Pharmacogenomics J. 5, 226-243 https://doi.org/10.1038/sj.tpj.6500320
- Mauritz, R., van Groeningen, C.J., Smid, K., Jansen, G., Pinedo, H.M., and Peters, G.J. (2007). Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression after administration of 5-fluorouracil to patients with colorectal cancer. Int. J. Cancer 120, 2609-2612 https://doi.org/10.1002/ijc.22626
- Miyamoto, S., Ochiai, A., Boku, N., Ohtsu, A., Tahara, M., Yoshida, S., Okabe, H., Takechi, T., and Fukushima, M. (2001). Discrepancies between the gene expression, protein expression, and enzymatic activity of thymidylate synthase and dihydropyrimidine dehydrogenase in human gastrointestinal cancers and adjacent normal mucosa. Int. J. Oncol. 18, 705-713
- Morganti, M., Ciantelli, M., Giglioni, B., Putignano, A.L., Nobili, S., Papi, L., Landini, I., Napoli, C., Valanzano, R., Cianchi, F., et al. (2005). Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers. Eur. J. Cancer 41, 2176-2183 https://doi.org/10.1016/j.ejca.2005.06.016
- Nita, M.E., Tominaga, O., Nagawa, H., Tsuruo, T., and Muto, T. (1998). Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5- fluorouracil in colorectal cancer. Hepatogastroenterology 45, 2117-2122
- Obama, K., Kanai, M., Kawai, Y., Fukushima, M., and Takabayashi, A. (2002). Role of retinoblastoma protein and E2F-1 transcription factor in the acquisition of 5-fluorouracil resistance by colon cancer cells. Int. J. Oncol. 21, 309-314
- Rustum, Y.M., Harstrick, A., Cao, S., Vanhoefer, U., Yin, M.B., Wilke, H., and Seeber, S. (1997). Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors. J. Clin. Oncol. 15, 389-400 https://doi.org/10.1200/JCO.1997.15.1.389
- Tanaka-Nozaki, M., Tajiri, T., Tanaka, N., Furukawa, K., Takasaki, H., Yoshimura, K., Suzuki, H., Naito, Z., Sugizaki, Y., Merk, H.F., et al. (2003). Intratumoral induction of thymidylate synthase mRNA by 5-FU in colorectal cancer patients: association with survival. Oncol. Rep. 10, 1425-1429
- Wu, M.W., Xian, L.J., Li, X.M., Pasquale, I., and Francis, L. (2004). Circadian expression of dihydropyrimidine dehydrogenase, thymidylate synthase, c-myc and p53 mRNA in mouse liver tissue. Ai zheng = Aizheng = Chinese J. Cancer 23, 235-242